Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volatile anaesthesia versus propofol for major cancer surgery feasibility trial
ACTRN12617001065381Phase 3Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Aug 2017
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of propofol, sevoflurane, isoflurane and desflurane in cancer (2 arms), sponsored by Peter MacCallum Cancer Centre. Primary endpoints: Recruitment feasibility and Successful delivery of assigned anaesthetic technique. Started Aug 2017; status: completed.
02
Drugs
propofolsevofluraneisofluranedesflurane
03
Conditions
cancer
Beyond the preview
Go deeper on ACTRN12617001065381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001065381.